Nanotechnology Teleconference
For anyone who is interested.
Tuesday, October 31, 2006 at 1:00 p.m. (EST)
The Impact of Nanotechnology Research on Cancer Patients
To learn more about how NCI's nanotechnology programs will help transform diagnosis, treatment, prevention, and clinical outcomes for cancer patients visit http://nano.cancer.gov/resource_center/exploring.asp.
USA Toll-Free: 1-800-857-6584
Passcode: NANOTECH
__________________
Kate
Stage IIIC Diagnosed Oct 25, 2005 (age 58)
ER/PR-, HER2+++, grade 3, Ploidy/DNA index: Aneuploid/1.61, S-phase: 24.2%
Neoadjunct chemo: 4 A/C; 4 Taxatore
Bilateral mastectomy June 8, 2006
14 of 26 nodes positive
Herceptin June 22, 2006 - April 20, 2007
Radiation (X35) July 24-September 11, 2006
BRCA1/BRCA2 negative
Stage IV lung mets July 13, 2007 - TCH
Single brain met - August 6, 2007 -CyberKnife
Oct 2007 - clear brain MRI and lung mets shrinking.
March 2008 lung met progression, brain still clear - begin Tykerb/Xeloda/Ixempra
|
Linear Mode
